Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to $19274.0.

  • Cirtran's Cash & Equivalents changed N/A to $19274.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19274.0, marking a year-over-year change of. This contributed to the annual value of $18081.0 for FY2022, which is 23042.76% up from last year.
  • According to the latest figures from Q3 2025, Cirtran's Cash & Equivalents is $19274.0.
  • Over the past 5 years, Cirtran's Cash & Equivalents peaked at $198891.0 during Q1 2023, and registered a low of $1210.0 during Q1 2025.
  • In the last 5 years, Cirtran's Cash & Equivalents had a median value of $18677.5 in 2022 and averaged $31971.9.
  • In the last 5 years, Cirtran's Cash & Equivalents skyrocketed by 42096.11% in 2023 and then tumbled by 9849.36% in 2024.
  • Over the past 5 years, Cirtran's Cash & Equivalents (Quarter) stood at $5472.0 in 2021, then skyrocketed by 230.43% to $18081.0 in 2022, then rose by 29.43% to $23402.0 in 2023, then plummeted by 87.2% to $2996.0 in 2024, then soared by 543.32% to $19274.0 in 2025.
  • Its Cash & Equivalents was $19274.0 in Q3 2025, compared to $4335.0 in Q2 2025 and $1210.0 in Q1 2025.